Rolls-Royce Holdings Plc backed away from electric powered aircraft, with plans to put a business making such engines

Rudy Giuliani’s former lawyer has sued him, alleging the ex-New York City mayor has paid only a fraction of nearly $1.6 million in legal fees he’s racked up from investigations into his efforts to keep Donald Trump in the White House

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

In Dubai, it’s normal to leave your air conditioning running at all times, even if you go away

Lewis Capaldi made a surprise appearance during a Peloton class this week, and naturally, he used the opportunity to hype spinners up the way the trainers notoriously do. The ride was actually to celebrate the singer's new album, Broken By Desire To Be Heavenly Sent, and saw the singer get sweaty alongside fans to his favourite songs. He even found time to shout a few Celtic chants in honour of his favourite football team. Click here to sign up for our newsletters

BYU has officially had its welcome to the Big 12 moment, thanks to none other than Kansas. Although Lance Leipold certainly has Kansas football in a fantastic p

Nebraska football has fallen off in recent years but new head coach Matt Rhule is saying and doing all the right things to rejuvenate the program.Matt Rhule has one job: Make Nebraska Nebraska again.The Cornhuskers used to be one of the premiere college football programs out there, winning c...

Caleb Williams refuses to commit to the 2024 NFL Draft, but there's every reason to believe the projected No. 1 pick will eventually be all-in on the NFL.

BEIJING (Reuters) -China's central bank on Monday said it will fend off systemic risks to the economy and guide financial

Elon Musk’s brain chip company Neuralink said on Thursday that it now has regulatory approval in the US to test its implants in human subjects. Neuralink has been building chips to be implanted into the skull for a brain-computer interface, claiming their development has the potential to help restore vision in the blind, and even help paralysed people walk again. While Mr Musk has said on several occasions since 2019 that the company is ready to go for experiments in humans to treat paralysis and blindness, the US Food and Drug Administration (FDA) had however rejected proposals by the company to begin human clinical trials. For instance, in early 2022, when Neuralink applied for human testing, the FDA rejected the proposal saying there were “dozens of issues the company must address”. These issues flagged by the FDA included the use of lithium batteries in Neuralink’s device and the likelihood of the implant’s wires interfering with the brain. The federal agency also expressed concerns about whether the firm’s implants can be removed without causing brain damage. Neuralink has also come under the scanner of at least one US government probe after animal rights watchdogs accused the firm of “inadequate care” of its research monkeys. Reuters previously reported that the brain chip company killed about 1,500 animals, including over 280 sheep, pigs and monkeys since 2018. The US Department of Agriculture also began investigating Neuralink’s potential violations of the Animal Welfare Act. Responding to the animal abuse complaints, the company said in a blogpost that it was “absolutely committed to working with animals in the most humane and ethical way possible”. “The use of every animal was extensively planned and considered to balance scientific discovery with the ethical use of animals,” it said. In a tweet in November last year, Mr Musk said he was confident that Neuralink’s device was “ready for humans”, adding that the timing for beginning human trials was a “function of working through the FDA approval process”. “We want to be extremely careful and certain that it will work well before putting a device into a human but we’ve submitted I think most of our paperwork to the FDA and probably in about six months we should be able to upload Neuralink in a human,” the Tesla and SpaceX chief said. On Thursday, the company said it has finally received approval from the federal agency to begin trials in humans. “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” the brain chip company said. The FDA approval “represents an important first step that will one day allow our technology to help many people”, Neuralink said, adding that it would soon announce more information on the recruitment of people for clinical trials. FDA hasn’t immediately responded to The Independent‘s queries on the Neuralink approval claim. Read More What is superintelligence? How AI could replace humans as the dominant lifeform on Earth Elon Musk’s Neuralink probed over shipment of ‘contaminated’ devices from ‘infected’ monkey brains When sci-fi becomes reality: could brain-machine interfaces be right around the corner?

The U.S. Justice Department is seeking more than $4 billion from Binance Holdings as part of a proposed

As South Korea struggles to get young people interested in marriage and kids, authorities are trying a new tack: importing foreign workers to carry some of the household burden.